|
Male, n (%)
|
163 (55)
|
121 (57)
|
42 (51)
|
6.7 (− 6.0–19.4)
|
|
Age, mean (SD)
|
58.0 (16.0)
|
57.2 (16.3)
|
60.0 (15.1)
|
−2.6 (− 1.4–6.7)
|
|
ICU Admission, n (%)
|
220 (75)
|
161 (76)
|
59 (71)
|
5.2 (−5.9–16.3)
|
|
Fluids Administered over 24 h, liters (mean, SD)
|
4161 (2881)
|
4454 (2940)
|
3420 (2596)
|
1034 (307–1761)
|
|
Lactate, mmol/L (mean, SD)
|
3.2 (2.8)
|
3.0 (2.3)
|
3.9 (3.7)
|
−0.9 (− 1.6–0.2)
|
|
Triage Vital Signs
|
|
Triage systolic blood pressure, mmHg (mean, SD)
|
108 (65)
|
109 (74)
|
106 (31)
|
3 (−13–19)
|
|
Triage heart rate, bpm (mean, SD)
|
107 (26)
|
109 (24)
|
103 (31)
|
6 (−1–12)
|
|
White blood cell count, cells/mL (mean, SD)
|
16.2 (10.2)
|
15.9 (10.1)
|
17.0 (10.3)
|
−1.1 (−3.7–1.5)
|
|
ED Charges, Total, dollars (median, IQR)
|
$3640 (2861 – 5234)
|
$3840 (2947 – 5661)
|
$3380 (2793 – 4356)
|
334 (71–653)
|
|
Hospital Facility Charges (median, IQR)
|
$2776 (2232 – 3706)
|
$2863 (2288 – 3772)
|
$2574 (2049 – 3264)
|
264 (63–482)
|
|
Professional Fees (median, IQR)
|
$760 (660–1496)
|
$1050 (681–1950)
|
$681 (660–1050)
|
19 (0–21)
|
|
Comorbidities
|
|
Peripheral vascular disease, n (%)
|
17 (6)
|
10 (5)
|
7 (8)
|
−3.7 (− 9.7–2.3)
|
|
Paralysis, n (%)
|
17 (6)
|
14 (7)
|
3 (4)
|
3.0 (− 2.9–9.0)
|
|
Neurologic disorders, n (%)
|
35 (12)
|
27 (13)
|
8 (10)
|
3.2 (− 5.1–11.4)
|
|
COPD, n (%)
|
47 (16)
|
32 (15)
|
15 (18)
|
−2.9 (− 12.3–6.4)
|
|
DM with complications, n (%)
|
23 (8)
|
20 (9)
|
3 (4)
|
5.9 (−1.0–12.7)
|
|
Hypothyroidism, n (%)
|
23 (8)
|
17 (8)
|
6 (7)
|
0.8 (−6.0–7.7)
|
|
Renal failure, n (%)
|
38 (13)
|
29 (14)
|
9 (11)
|
2.9 (−5.7–11.5)
|
|
Liver disease, n (%)
|
42 (14)
|
23 (11)
|
19 (23)
|
−12.0 (−20.8 - -3.1)
|
|
Metastatic cancer, n (%)
|
18 (6)
|
11 (5)
|
7 (8)
|
−3.2 (−9.3–2.9)
|
|
Solid tumor without metastasis, n (%)
|
16 (5)
|
8 (4)
|
8 (10)
|
−5.8 (−11.6 - -0.1)
|
|
Coagulopathy, n (%)
|
53 (18)
|
30 (14)
|
23 (28)
|
−13.4 (−23.2 - -3.7)
|
|
Fluid and electrolyte disorders, n (%)
|
231 (79)
|
153 (73)
|
78 (94)
|
−21.4 (−31.7 - -11.3)
|
|
Deficiency anemia, n (%)
|
34 (12)
|
30 (14)
|
4 (5)
|
9.4 (1.2–17.5)
|
|
Hypertension, n (%)
|
96 (32)
|
7 (3)
|
5 (6)
|
17.0 (5.1–28.8)
|
|
APACHE-II score (mean, SD)
|
16.9 (7.0)
|
16.2 (6.5)
|
18.6 (7.8)
|
−2.4 (−4.1 - -0.6)
|
|
28-day ICU-free days (median, IQR)
|
22 (0–26)
|
25 (22–26)
|
0 (0–0)
|
25 (24–25)
|
|
28-day hospital free days (median, IQR)
|
12 (0–21)
|
18 (10–22)
|
0 (0–0)
|
18 (17–20)
|
